NCT00809601

Brief Summary

There are different kinds of ear tubes that may be inserted into the tympanic membrane to relieve recurrent acute otitis and hearing impairment due to otitis media with effusion. The tubes differ in size, shape and material. No-one knows if there are differences between the different kinds of tubes regarding complications. The investigators' hypothesis is that there is differences between the different kinds of tubes regarding complications. To test the investigators' hypothesis, the investigators are about to conduct a randomized controlled study of four kinds of tubes having two different material and two different shapes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 2, 2008

Completed
8 months until next milestone

First Posted

Study publicly available on registry

December 17, 2008

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

March 22, 2013

Status Verified

March 1, 2013

Enrollment Period

6.3 years

First QC Date

May 2, 2008

Last Update Submit

March 21, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to complete expulsion of the ventilation tube from the tympanic membrane

    45 months

Secondary Outcomes (6)

  • Persistent tympanic membrane perforation

    45 months

  • Need for tube extraction (pain or infection)

    45 months

  • Pain leading to health care contact

    45 months

  • Tube related ear infection

    45 months

  • Obstruction of the tube

    45 months

  • +1 more secondary outcomes

Study Arms (1)

1

EXPERIMENTAL
Device: Insertion of a specific type of ventilation tube through the tympanic membrane

Interventions

The ventilation tubes are tested using one type in one ear and another type as an active comparator in the other ear. The investigators will test in total 4 different kinds of tubes. Four different combinations of tubes will be tested. The first combination will test: "Shepard tube" (double flanged, Fluoroplastic) vs "Donaldson tube" (double flanged, silicone) The second combination will test: "Straight tube" (single flanged, Fluoroplastic) vs "Armstrong" (single flanged, silicone) The third combination will test: "Armstrong" (single flanged, silicone) vs "Donaldson tube" (double flanged, silicone) The fourth combination will test: "Straight tube" (single flanged, Fluoroplastic) vs "Shepard tube" (double flanged, Fluoroplastic)

1

Eligibility Criteria

Age1 Year - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 1-10 planned for bilateral ventilation tubes

You may not qualify if:

  • Ongoing ear infection
  • Previous insertion of ventilation tube

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Danderyds Hospital

Stockholm, Stockholm County, 18288, Sweden

Location

MeSH Terms

Conditions

Otitis Media

Condition Hierarchy (Ancestors)

OtitisEar DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Magnus von Unge, MD, PhD

    ENT-dept Karolinska Hospital

    PRINCIPAL INVESTIGATOR
  • Johan Knutsson, MD

    Centre for clinical research Vastmanland

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

May 2, 2008

First Posted

December 17, 2008

Study Start

May 1, 2008

Primary Completion

September 1, 2014

Study Completion

September 1, 2015

Last Updated

March 22, 2013

Record last verified: 2013-03

Locations